Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease - 2nd cohort

ABSTRACT: In order to identify differentially abundant proteins, human plasma samples from COVID-19 patients with either a mild or moderate (MM) or a critical or severe (CS) disease course from acute phase of infection were analyzed on antibody microarrays 998 different proteins by 1,425 antibodies.

ORGANISM(S): Homo sapiens

SUBMITTER:  

PROVIDER: E-MTAB-12777 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): E-MTAB-12779

REPOSITORIES: biostudies-arrayexpress